Clinical research by Comprehensive Cancer Infrastructures for the benefit of patients with common cancers
Supporting the implementation of the Cancer Mission · HORIZON-IA · Needs partners
What this call funds
This call funds clinical research led by comprehensive cancer infrastructures to improve diagnosis and treatment of lung, bowel, breast and prostate cancer. Proposals must pilot and scale innovative diagnostic or treatment programmes across at least four EU countries, including one with less developed cancer care infrastructure, to reduce inequalities in cancer care. The goal is tangible benefits for patients, better tools for clinicians and researchers, and evidence to guide policymakers on rolling out these programmes more widely.
public health · biotechnology · medical devices · diagnostics · digital health · regional development
Who wins this
A consortium of public or private cancer centres, hospitals, university medical centres or research institutes across multiple countries that wants to run multinational clinical research and piloting programmes for major cancer types.
Could you win this call?
Only the website is required.
The call in detail
- Indicative grant size
- €7M to €10M
- Funding model
- Lump sum. Paid per completed work package, with no financial reporting of actual costs
- Submission
- Single-stage submission (full proposal at once)
- Type of action
- HORIZON Innovation Actions
- Partners
- Required. The call asks for a consortium: from 4 countries.
- Eligible applicants
- research organisation, public body, hospital, university medical centre, company, non-profit
- Also required
- Projects must pilot and upscale innovative diagnostic or treatment programmes in at least four EU Member States or Associated Countries, one of which must have a less developed comprehensive cancer infrastructure, and evaluation thresholds are 4 for each of Excellence, Impact and Implementation with a cumulative threshold of 12.
- Eligible countries (45)
- Austria, Belgium, Bulgaria, Croatia, Cyprus, Czechia, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, Netherlands, Poland, Portugal, Romania, Slovakia, Slovenia, Spain, Sweden, Norway, Iceland, Switzerland, United Kingdom, Israel, Türkiye, Ukraine, Serbia, North Macedonia, Montenegro, Albania, Bosnia and Herzegovina, Kosovo, Georgia, Armenia, Moldova, Tunisia, New Zealand
Read the full conditions from the official call ›
General conditions 1. Admissibility conditions: Proposal page limit and layout described in Annex A and Annex E of the Horizon Europe Work Programme General Annexes. Proposal page limits and layout: described in Part B of the Application Form available in the Submission System. 2. Eligible countries described in Annex B of the Work Programme General Annexes. A number of non-EU/non-Associated Countries that are not automatically eligible for funding have made specific provisions for making funding available for their participants in Horizon Europe projects. See the information in the Horizon Europe Programme Guide. 3. Other Eligibility Conditions described in Annex B of the Work Programme General Annexes. 4. Financial and operational capacity and exclusion described in Annex C of the Work Programme General Annexes. 5a. Evaluation and award: Award criteria, scoring and thresholds described in Annex D of the Work Programme General Annexes. 5b. Evaluation and award: Submission and evaluation processes The thresholds for each criterion will be 4 (Excellence), 4 (Impact) and 4 (Implementation). The cumulative threshold is 12. described in Annex F of the Work Programme General Annexes and the Online Manual. 5c. Evaluation and award: Indicative timeline for evaluation and grant agreement described in Annex F of the Work Programme General Annexes. 6. Legal and financial set-up of the grants Eligible costs will take the form of a lump sum as defined in the Decision of 7 July 2021 authorising the use of lump sum contributions under the Horizon Europe Programme – the Framework Programme for Research and Innovation (2021-2027) – and in actions under the Research and Training Programme of the European Atomic Energy Community (2021-2025) [[This decision is available on the Funding and Tenders Portal, in the reference documents section for Horizon Europe, under ‘Simplified costs decisions’ or through this link: https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/horizon/guidance/ls-decision_he_en.pdf ]]. The granting authority may, up to 4 years after the end of the action, object to a transfer of ownership or to the exclusive licensing of results, as set out in the specific provision of Annex 5. described in Annex G of the Work Programme General Annexes. Specific conditions described in the specific topic of the Work Programme
Who has won calls like this
Organisations that most often win this call family · 72 past winners